Dr. Heidi Ko, medical oncologist and recognized leader in the oncology diagnostics field, presented during an Ask the Expert webinar in collaboration with Outcomes4Me. She examined the tumor-agnostic biomarker, HER2 (human epidermal growth factor receptor 2), and the role it plays in cancer care.
Watch our webinar to learn more:
- Why testing for biomarkers in all cancer types is important for personalized care
- How a biomarker called HER2 can be useful for a new targeted therapy for patients with cancer
- How doctors can test for HER2 and what those results mean
- What the future might hold for HER2 testing and cancer treatment